Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2007
07/12/2007US20070161677 Bisarylurea derivatives
07/12/2007US20070161651 Tie-2 modulators and methods of use
07/12/2007US20070161650 4-[2-(4'-Fluoro-biphenyl-4-yloxy)-acetylamino]-thiophene-3-carboxylic acid, a G protein coupled receptor(HM74A) activator, for the treatment and/or prevention of diseases such as increased lipid and cholesterol levels; side effect reduction
07/12/2007US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS
07/12/2007US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5)
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
07/12/2007US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof
07/12/2007US20070161624 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
07/12/2007US20070161574 Hcv ns-3 serine protease inhibitors
07/12/2007DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases
07/12/2007DE19624590B4 2,2-Difluor-1,3-dioxane, diese enthaltendes flüssigkristallines Medium, deren Verwendung und Zwischenprodukte (1,3-Dioxan-2-thione) 2,2-difluoro-1,3-dioxane, these liquid-crystalline medium containing, their use and intermediates (1,3-dioxan-2-thione)
07/12/2007CA2635580A1 Substituted bis-amide metalloprotease inhibitors
07/12/2007CA2634195A1 Piperazine compounds with a herbicidal action
07/12/2007CA2634037A1 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation
07/12/2007CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors
07/12/2007CA2633483A1 Piperazine compounds with a herbicidal action
07/11/2007EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses
07/11/2007EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
07/11/2007EP1805164A2 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
07/11/2007EP1805163A2 1,1a,5,5a-tetrahydro-3-thia-cyclopropa¬a|pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists
07/11/2007EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
07/11/2007EP1805155A1 Thrombopoietin activity modulating compounds and methods
07/11/2007EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
07/11/2007EP1497287A4 Quinolinone derivatives
07/11/2007EP1175398B1 Indoline derivatives as progesterone antagonists
07/11/2007EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity
07/11/2007EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents
07/11/2007CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
07/11/2007CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives
07/11/2007CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors
07/11/2007CN1325472C Phenyl-substituted cyclic enaminones
07/11/2007CN1325052C Benzothiazole derivatives
07/11/2007CN1324964C Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
07/10/2007US7241887 3-azabicyclo[3.2.1]octane derivatives
07/10/2007US7241795 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp., Pneumocystis carinii, Toxoplasma gondii, Fusarium solani, and Cryptococcus neoformans
07/10/2007US7241794 Nonnucleoside reverse transcriptase inhibitors
07/10/2007US7241793 For therapy of cardiovascular diseases
07/10/2007US7241791 Substituted 4-(indazol-3-yl)phenols
07/10/2007US7241774 Amines such as 6,7-bis-hydroxy-1-biphenyl-4-ylmethyl-1,2,3,4-tetrahydro-isoquinoline, used as preferential anticarcinogenic agents
07/10/2007US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives
07/10/2007CA2276463C Substituted 4-benzoyl-pyrazoles
07/05/2007WO2007076104A1 Vanilloid receptor ligands and their use in treatments
07/05/2007WO2007075487A2 Substituted aromatic heterocyclic compounds as fungicides
07/05/2007WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia.
07/05/2007WO2007058392A9 Heterocyclic compound and medicinal application thereof
07/05/2007WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
07/05/2007WO2007017764A3 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity
07/05/2007WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
07/05/2007US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
07/05/2007US20070155810 Enzyme inhibitors as bactericides for infections and enzyme inhibitors
07/05/2007US20070155795 Muscarinic agonists
07/05/2007US20070155793 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
07/05/2007US20070155790 Meta-benzamidine derivatives as serine protease inhibitors
07/05/2007US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto
07/05/2007US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
07/05/2007US20070155729 Therapeutic amine-arylsulfonamide conjugate compounds
07/05/2007US20070155721 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
07/05/2007US20070155719 Platelet ADP receptor inhibitors
07/05/2007US20070155701 Keto cannabinoids with therapeutic indications
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007US20070154980 Fluorescent dyes
07/05/2007DE102005062985A1 Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted bis (hetero) aromatic N-Ethylpropiolamide and their use for the preparation of medicaments
07/05/2007DE102005061430A1 Substituierte Imidazolin-Derivate Substituted imidazoline derivatives
07/05/2007CA2632565A1 Substituted aromatic heterocyclic compounds as fungicides
07/05/2007CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
07/04/2007EP1803721A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
07/04/2007EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
07/04/2007EP1803709A1 Proton pump inhibitors
07/04/2007EP1803706A1 HIV protease inhibitors based on amino acid derivatives
07/04/2007EP1802634A2 Thiophens and their use as anti-tumor agents
07/04/2007EP1802630A2 Trityl derivatives for enhancing mass spectrometry
07/04/2007EP1802615A1 Phosphodiesterase 4 inhibitors
07/04/2007EP1802611A2 Heterocyclic diamide insecticidal agents
07/04/2007EP1802609A2 Thrombin receptor antagonists
07/04/2007EP1802602A1 Substituted dipiperdine ccr2 antagonists
07/04/2007EP1802588A1 Substituted amino-pyrimidones and uses thereof
07/04/2007EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
07/04/2007EP1565450B1 Tetrahydropyran derivatives
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP1260512B1 Novel cyclic amide derivatives
07/04/2007CN1993353A Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
07/04/2007CN1993352A Piperazine derivatives with CCR3 inhibiting activity
07/04/2007CN1993346A Novel thiophene derivatives
07/04/2007CN1993329A Quinoline derivatives as neurokinin receptor antagonists
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/04/2007CN1989969A Cyclic protein tyrosine kinase inhibitors
07/04/2007CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
07/04/2007CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors
07/04/2007CN1324015C Pyridine and pyrimidine derivatives
07/04/2007CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
07/04/2007CN1324012C TNF-alpha prodn. inhibitors
07/03/2007US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents
07/03/2007US7238811 Chemical compounds